The latest from Mayo Clinic Laboratories
The newsroom features stories of Mayo Clinic Laboratories and its experts in the news. For media inquiries and expert interviews, contact the Media Relations Newsroom at email@example.com, attention: Mayo Clinic Laboratories.
The NIH has awarded $40 million to Mayo Clinic to develop a comprehensive biorepository as the source of clinical samples for long COVID research studies.
Representing Mayo Clinic at the event, Dr. William Morice contributed his expertise and experience as leaders from around the world redoubled their commitment to end the COVID-19 pandemic.
Director of Mayo Clinic’s Infectious Diseases Serology Laboratory, Elitza Theel, Ph.D., joins a discussion about COVID-19 antibody testing in a recent story on NPR.
Personalized medicine represents unprecedented potential benefits for patients. LabConnect and Mayo Clinic BioPharma Diagnostics are working together to bring world-class laboratory testing and resources to industry partners conducting clinical research and trials.
In this month’s “Hot Topic,” Brad Karon, M.D., Ph.D., reviews the results of a study that Mayo Clinic recently published comparing four different rapid antigen tests for novel coronavirus.
Mayo Clinic Laboratories has been key to Minnesota’s COVID-19 testing strategy since the start of the pandemic. At their height in 2020, Mayo’s COVID-19 labs were running 24/7, processing up to 90,000 COVID-19 specimens a day. Dr. Morice explains what Mayo Clinic Laboratories is doing now to handle the latest surge.
With a spike in cases spurred by the delta virus, demand for COVID-19 testing is on the rise again, and several at-home tests that have been approved for emergency use authorization are becoming more popular. But should you rely on a test that you administer yourself to tell you whether you have COVID-19? Dr. Matthew Binnicker explains the pros and cons of at-home tests.
In the wake of the CDC withdrawing its emergency use authorization request for a coronavirus PCR test, social media posts claimed the action signaled that the tests were flawed. Dr. Matthew Binnicker explains why those claims are false.
Mayo Clinic Laboratories reaches patients around the globe. Alumni magazine highlights this work as it details the labs' international strategy.
Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory in Mayo Clinic’s Division of Clinical Microbiology, considers the prospects for COVID-19 this fall as the traditional influenza season ramps up.
In this episode, Dr. Morice and Dr. Pritt talk about what the recent surge in COVID-19 cases means and how we can all do our part to help prevent further spread.